Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1168 (LINC01168) would be classified as a long intergenic non-coding RNA (lincRNA), a subclass of long non-coding RNAs (lncRNAs), which are defined as RNA transcripts longer than 200 nucleotides that do not encode proteins and do not overlap with protein-coding genes[1][3]. lincRNAs may be involved in gene regulation and can play roles in various cellular processes, but most are not considered established therapeutic targets, and for LINC01168 specifically, there is a lack of published biological or disease association data. The available biomedical literature instead discusses LINC01116 (note the different number), which is a functionally relevant lincRNA with emerging roles in cancer biology[2]. There is no credible information on LINC01168 as a distinct, functionally characterized, or clinically relevant molecule. This likely indicates a typographical or database error, conflation with the more-studied LINC01116, or possibly a hypothetical gene annotation without experimental validation. Note: The canonical and alias names provided match the query, but there appears to be no scientific characterization or evidence that "LINC01168" is a functional or recognized gene/target. All meaningful biological and disease associations, mechanisms, and therapeutic data are for "LINC01116" (not 1168). If LINC01168 is the intended query, current databases do not support its existence as a therapeutic target or biomarker. If this is a typographical error and the intended target is LINC01116, see [2] for comprehensive details.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1168 (LINC01168).